Tropicamide

托品卡胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTropicamide
Drug Alias Name托品酰胺Tropicamida托吡卡胺Intra-oral slow dissolving muco-adhesive tropicamide thin filmTropicamidum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCycloplegiaDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1 +[4] 
Global Approved IndicationsCycloplegiaMydriasis
Approved Indications in ChinaMydriasis
Original Approved Country/TerritoryUnited States
Original Approved Date1960/02/23
Country/TerritoryUnited StatesIranMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSemnan University Of Medical SciencesWuxi Jimincare Shanhe Pharmaceutical Co Ltd
Inactive CompaniesAlcon
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Mydriasis
Inactive IndicationsCycloplegia

Other Information

ATC CodeS01FA06
Related LinksWikipediaDrugBankKEGG